CAS No. |
32476-67-8 |
中文名称 |
4-((3S,5S,8R,9S,10R,13R,14S,17R)-5,14-二羟基-3-(((2R,4S,5R,6R)-5-羟基-4-甲氧基-6-甲基四氢-2H-吡喃-2-基)氧基)-10,13-二甲基六十氢-1H-环戊二烯并[a]菲-17-基)呋喃-2(5H)-酮 |
英文名称 |
4-((3S,5S,8R,9S,10R,13R,14S,17R)-5,14-dihydroxy-3-(((2R,4S,5R,6R)-5-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one |
别名 |
4-[(3S,5S,10R,13R,14S,17S)-5,14-dihydroxy-3-[(2S,5R)-5-hydroxy-4-methoxy-6-methyl-oxan-2-yl]oxy-10,13-dimethyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-5H-furan-2-one;Card-20(22)-enolide, 3-[(2,6-dideoxy-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-, (3β,5β)- (9CI);proliferation,inhibit,Inhibitor,cardiac,Periplocymarin,U937,anti-cancer,HCT-8,cells,glycoside,PC3 |
标准英文名 |
4-((3S,5S,8R,9S,10R,13R,14S,17R)-5,14-dihydroxy-3-(((2R,4S,5R,6R)-5-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one |
MDL No. |
MFCD01740198 |
分子式 |
C30H46O8 |
分子量 |
534.69
|
精确分子量 |
534.32
|
SMILES |
CO[C@H]1C[C@H](O[C@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)O[C@H](C)[C@H]1O |
标准SMILES |
C[C@H]1O[C@H](C[C@H](OC)[C@@H]1O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@]4(C)[C@H](CC[C@]4(O)[C@@H]3CC[C@]2(O)C1)C1COC(=O)C=1 |
用途 |
Periplocymarin is a cardiotonic glycoside isolated from Periploca sepium and Periploca graeca, exhibiting potent anti-cancer activity; it inhibits the proliferation of various cancer cell lines in vitro, including PC3, U937, HCT-8, Bel-7402, BGC823, A549, and A2780, with IC50 values ranging from 0.02 to 0.29 µM. |
InChIKey |
XRWQBDJPMXRDOQ-YUUDFPFBSA-N |